White & Case has appointed David Albagli as a local partner in its intellectual property practice in Tokyo from Finnegan Henderson Farabow Garrett & Dunner. 

Albagli’s practice focuses on IP issues including patent portfolio strategy development as well as patent litigation, prosecution, opinion work, plus due diligence investigations and pre-litigation counseling. He also has experience in transactional IP and patent matters, particularly in pharmaceuticals and biotechnology, including chemicals, polymers, semiconductors and medical devices.

“Japan is the second largest pharmaceutical market in the world and it’s also the third largest chemical producer in the world. David’s arrival underlines our commitment to our clients in these important industries. His background as both a scientist and IP lawyer is very impressive, and makes him uniquely positioned to assist clients with complex IP issues in the chemicals, pharmaceutical and broader life sciences sectors,” said Brian Strawn, executive partner of the White & Case’s Tokyo office, in a statement.